71
Views
0
CrossRef citations to date
0
Altmetric
Evidence to Practice

Optimizing weight control in diabetes: antidiabetic drug selection

, , , &
Pages 297-299 | Published online: 27 Sep 2022

References

  • Norris SL Zhang X Avenell A Long term non-pharmacologic weight loss interventions for adults with Type 2 diabetes Cochrane Database Syst Rev 2005 2 CD004095 15846698
  • Anderson JW Kendall CW Jenkins DJ Importance of weight management in Type 2 diabetes: Review with meta-analysis of clinical studies J Am Coll Nutr 2003 22 5 331 339 14559925
  • Colagiuri S Diabesity: Therapeutic options Diabetes Obes Metab 2010 12 6 463 473 20518802
  • Wolf AM Siadaty M Yaeger B Effects of lifestyle intervention on health care costs. Improving Control with Activity and Nutrition (ICAN) J Am Diet Assoc 2007 107 8 1365 1373 17659904
  • Mitri J Hamd O Diabetes medications and body weight Expert Opin Drug Saf 2009 8 5 573 584 19538102
  • Derosa G Tinelli C Mafiolli P Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes Diabetes Obes Metab 2010 11 12 1091 1099 19765050
  • UK Prospective Diabetes Study (UKPDS) Relative efficacy of randomly allocated diet, sulfonylurea, insulin or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years BMJ 1995 310 6972 83 88 7833731
  • Belsey J Krishnarajah G Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: A meta-analysis Diabetes Obes Metab 2008 10 Suppl 1 1 7 18435668
  • Johnson JL Wolf SL Kabadi UM Efficacy of insulin and sulfonylurea combination therapy in Type II diabetes. A meta-analysis of the randomized placebo-controlled trials Arch Intern Med 1996 156 3 259 264 8572835
  • Johansen K Efficacy of metformin in the treatment of NIDDM. Meta-analysis Diabetes Care 1999 22 1 33 37 10333900
  • Del Prato S Erkelens DW Leutenegger M Six-month efficacy of benflurox vs. placebo or metformin in diet failed Type 2 diabetic patients Acta Diabetol 2003 40 1 20 27 12682825
  • Van de Laar FA Lucassen PL Akkermans RP Alpha-glucosidase inhibitors for patients with Type 2 diabetes: Results from a Cochrane systematic review and meta-analysis Diabetes Care 2005 28 1 154 163 15616251
  • Negishi M Shimomura K Proks P Shimomura Y Mori M Alpha glucosidase inhibitor voglibose can prevent pioglitazone-induced body weight gain in Type 2 diabetic patients Br J Clin Pharmacol 2008 66 2 318 319 18507653
  • Amori RE Lau J Pittas AG Efficacy and safety of incretin therapy in Type 2 diabetes. Systematic review and meta-analysis JAMA 2007 298 194 206 17622601
  • Monami M Marchionni N Mannucci E Long-acting insulin analogues versus NPH human insulin in Type 2 diabetes. A meta-analysis Diabetes Res Clin Pract 2008 81 2 184 189 18495286
  • Lasserson DS Glasziou P Perera R Holman RR Farmer AJ Optimal insulin regimens in Type 2 diabetes mellitus: Systematic review and meta-analyses Diabetologia 2009 52 10 1990 2000 19644668
  • Bazzano LA Lee LJ Shi L Reynolds K Jackson JA Fonseca V Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: A meta-analysis of randomized controlled trials Diabet Med 2008 25 8 924 932 18959605